Start here if you're new
what it is
Interlink makes touch, force, gas, and wearable sensors that help machines feel what your fingers, pressure, or environment are doing.
how it gets paid
Last year Interlink Elect made $12M in revenue. force-sensing resistor sensors was the main engine at $3.6M, or 30% of sales.
what just happened
The latest quarter this page tracks printed about $2.96M in revenue (versus ~$3.10M expected)—not $9M, which would blow past the $12M annual base. EPS stayed negative and the business remained unprofitable on an operating basis.
At a glance
C++ balance sheet — some cracks in the foundation
45/100 earnings predictability — expect surprises
negative earnings — ROC screens read positive while the core op is underwater; reconcile the period
-$0.16 fy2024 eps est
$12M fy2024 rev est
xvary composite: 42/100 — below average
What they do
Interlink makes touch, force, gas, and wearable sensors that help machines feel what your fingers, pressure, or environment are doing.
This is a niche parts business, not a platform fairy tale. Interlink has 102 employees and sells specialized human-machine interface hardware, which means your customer sticks around if redesigning the product is a pain. The edge is fit, not scale, and that only matters if gross margin stays near 41.2%.
How they make money
$12M
annual revenue
force-sensing resistor sensors
$3.6M
trackpads and cursor controls
$2.6M
wearable and textile sensors
$1.8M
gas sensors and instruments
$1.6M
firmware and integration services
$1.4M
other hmi modules
$1.0M
The products that matter
human-machine interface components
Force/Touch Sensors
$3.6M FSR · 30% of revenue
force-sensing resistors are the largest single line on the segment table. it is the center of gravity, but not big enough to absorb a weak quarter.
main revenue line
environmental sensing components
Trackpads & other HMI
$2.6M + $1.4M + $1.0M cluster
cursor controls, firmware/services, and other HMI modules stack next to FSR. add gas (~$1.6M) and wearables (~$1.8M) from the table and you have the full $12M map.
second revenue line
Key numbers
-17.6%
operating margin
Negative → the core operation loses money. So what: revenue growth alone does not fix that until overhead and scale catch up.
$12M
annual revenue
This is a very small revenue base. Plain English: one contract matters too much. So what: your upside and your risk both get magnified.
41.2%
gross margin
Gross margin means what is left after making the product. Plain English: the product itself is not terrible. So what: the problem is overhead and scale.
$1M
long-term debt
Debt is low versus revenue and capital. Plain English: the balance sheet is not the main fire today. So what: execution is the fire.
Financial health
C++
strength
- balance sheet grade C++ — below average — limited financial resources
- risk rank 3 — safer than 50% of stocks
- price stability 10 / 100
- long-term debt $1M (1% of capital)
C++ — below average. watch for debt servicing and cash burn.
Total return vs. market
Return history isn't available for LINK right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Revenue came in at about $2.96M versus ~$3.10M expected, while EPS was -$0.09 and the business stayed unprofitable.
Prior hero copy used $9M quarterly revenue—that cannot sit next to a $12M annual total and the $2.96M / $3.10M compare in risk. vs. prior year % on tiny bases can look huge; FY2024 EPS was still estimated around -$0.16—losses are the through-line.
$2.96M
revenue (Q)
-$0.09
eps (Q)
41.2%
gross margin (Q)
the number that mattered
The number that mattered was -17.6% operating margin because revenue spikes mean less if the core business still loses money.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
Your top risk is small-scale execution failure. LINK only does about $12M in annual revenue, so a modest miss or estimate cut can hit the story fast.
med
another small revenue miss would not be small
The last quarter came in at $2.96M versus a $3.10M estimate. That is only a $140,000 gap, but it already counted as a 4.5% miss.
If revenue stays below about $3M a quarter, the path to $12M annual scale stays cramped and 2026 guidance gets harder to trust.
med
one analyst is not a consensus
The only published price target on this page is $8.67 from one analyst. That is a data point, not market-wide conviction.
If that analyst cuts estimates again or drops coverage, shareholders lose the only outside model anchoring the upside case.
med
gross margin has not produced profits
A 41.2% gross margin sounds decent for a component business. FY2024 EPS is still estimated at -$0.16.
That gap tells you operating costs are doing the damage. Until the loss narrows, margin talk stays half the story.
med
development funding helps, but scale wins the argument
The NIH grant totals $280,000. That is useful money for a microcap, but it is not enough to remake the business.
At about 2.3% of annual revenue, the grant supports work. It does not fix execution, coverage, or profitability.
A $140,000 miss already broke the quarter. That tells you how little margin for error this story has.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
quarterly revenue getting back above the estimate line
The last print was $2.96M versus $3.10M expected. You want to see a clean beat or at least a return above $3M, not another small miss dressed up as progress.
trend
2026 EPS revisions
The single 2026 EPS estimate sits at -$0.04 and is 38.6% worse than prior projections. If that number drops again, the turnaround case gets thinner.
calendar
the next guidance update
Management has pointed investors toward 2026 earnings. The next update matters because this stock now trades on proof, not promise.
risk
coverage staying alive
One analyst covers the stock and carries an $8.67 target. Any change in coverage will hit sentiment because there is no deep bench of outside views here.
Analyst rankings
earnings predictability
45 / 100
in human-speak, analysts do not see a steady earnings pattern here.
balance sheet grade
C++
That is below average balance sheet grade. You are not looking at a fortress balance sheet.
price stability
10 / 100
The stock does not trade like a safe utility. It moves like a small cap people can change their minds on fast.
source: institutional data
Institutional activity
institutional ownership data for LINK is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$3
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive